269 related articles for article (PubMed ID: 33865976)
1. Laser diffraction as a powerful tool for amorphous solid dispersion screening and dissolution understanding.
Paisana MC; Lino PR; Nunes PD; Pinto JF; Henriques J; Paiva AM
Eur J Pharm Sci; 2021 Aug; 163():105853. PubMed ID: 33865976
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
Nunes PD; Pinto JF; Henriques J; Paiva AM
Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
[TBL] [Abstract][Full Text] [Related]
3. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
4. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
5. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
[TBL] [Abstract][Full Text] [Related]
6. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
Verma S; Rudraraju VS
AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
8. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
9. Variation in Supersaturation and Phase Behavior of Ezetimibe Amorphous Solid Dispersions upon Dissolution in Different Biorelevant Media.
Elkhabaz A; Sarkar S; Dinh JK; Simpson GJ; Taylor LS
Mol Pharm; 2018 Jan; 15(1):193-206. PubMed ID: 29161509
[TBL] [Abstract][Full Text] [Related]
10. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
11.
Bachmaier RD; Monschke M; Faber T; Krome AK; Pellequer Y; Stoyanov E; Lamprecht A; Wagner KG
Int J Pharm X; 2021 Dec; 3():100076. PubMed ID: 33851133
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
[TBL] [Abstract][Full Text] [Related]
13. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
14. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS
Mol Pharm; 2014 Oct; 11(10):3565-76. PubMed ID: 25185035
[TBL] [Abstract][Full Text] [Related]
15. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
Hate SS; Reutzel-Edens SM; Taylor LS
Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350
[TBL] [Abstract][Full Text] [Related]
16. A Simultaneous Differential Scanning Calorimetry-X-ray Diffraction Study of Olanzapine Crystallization from Amorphous Solid Dispersions.
Askin S; Gonçalves AD; Zhao M; Williams GR; Gaisford S; Craig DQM
Mol Pharm; 2020 Nov; 17(11):4364-4374. PubMed ID: 33074007
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Three-Fluid Nozzle Spraying Process for Facilitating Spray Drying of Hydrophilic Polymers for the Creation of Amorphous Solid Dispersions.
Mueller LK; Halstenberg L; Di Gallo N; Kipping T
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004521
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Konno H; Handa T; Alonzo DE; Taylor LS
Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
